CNS diseases and uveitis

Journal of Ophthalmic and Vision Research

Volumn 6, Issue 4, 2011, Pages 284-308

  Allegri, Pia ^a   Rissotto, Roberto ^b   Herbort, Carl P ^c,d   Murialdo, Ugo ^a  

^a Rapallo Hospital   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c Centre for Ophthalmic Specialized Care (COS)   (Switzerland)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

CNS inflammatory and infectious diseases; Eye inflammatory and infectious diseases; Uveitis

Indexed keywords

EID: 84855582678     PISSN: 20082010     EISSN: 2008322X     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Smith JR, Rosenbaum JT. Neurological concomitants of uveitis. Br J Ophthalmol 2004;88:1498-1499
2. Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Huseyin Altunbas H, Urgancioglu M. Uveitis in Behçet disease: an analysis of 880 patients. Am J Ophthalmol 2004;138:373-380
3. Tugal-Tutkun I. Behçet's disease. In: Gupta A, Gupta V, Herbort CP, Khairallah M (eds). Uveitis: Text and Imaging. 1st ed. New Delhi: Jaypee Brothers Medical Publishers Ltd; 2009: 397-413
4. Maca SM, Scharitzer M, Barisani-Asenbauer T.Uveitis and neurologic diseases: an often overlooked relationship. Wien Klin Wochenschr 2006;118:273-279
5. Brazis PW, Stewart M, Lee AG. The uveo-meningeal syndromes. Neurologist 2004;10:171-184
6. Díaz-Valle D, Méndez R, Arriola P, Cuiña R, Ariño M. Non-infectious systemic diseases and uveitis. An Sist Sanit Navar 2008;31:97-110
7. Guex-Crosier Y, Rochat C, Herbort CP. Necrotizing herpetic retinopathies. A spectrum of herpetic diseases determined by the immune state of the host. Ocul Immunol Inflamm 1997;5:259-265
8. Tugal-Tutkun I, Otük-Yasar B, Altinkurt E. Clinical features and prognosis of herpetic anterior uveitis: a retrospective study of 111 cases. Int Ophthalmol 2010;30:559-565
9. Schwoerer J, Othenin-Girard P, Herbort CP. Acute retinal necrosis: a new pathophysiological hypothesis. Ophthalmologica 1991;203:172-175
10. Holland GN. Standard diagnostic criteria for the acute retinal necrosis syndrome. Executive Committee of the American Uveitis Society. Am J Ophthalmol 1994;117:663-667
11. Forster DJ, Dugel PU, Frangieh GT, Liggett PE, Rao NA. Rapidly progressive outer retinal necrosis in the acquired immunodeficiency syndrome. Am J Ophthalmol 1990;110:341-348
12. Herbort CP, Buechi ER, Piguet B, Zografos L, Fitting P. High-dose oral acyclovir in acute herpes zoster ophthalmicus: the end of the corticosteroid era. Curr Eye Res 1991;10:171-175
13. Boivin G. Diagnosis of herpes virus infections of the central nervous system. Herpes 2004;11:48A-56A.
14. Tyler KL. Update on herpes simplex encephalitis. Rev Neurol Dis 2004;1:169-178
15. Perez VL, Foster CS. Uveitis with neurological manifestations. Int Ophthalmol Clin 2001;41:41-59
16. Holland GN, Vaudaux JD, Shiramizu KM, Yu F, Goldenberg DT, Gupta A, et al. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000). Am J Ophthalmol 2008;145: 12-22
17. Rathsam-Pinheiro RH, Boa-Sorte N, Castro-Lima Vargens C, Pinheiro CA, Castro-Lima H, Galvão-Castro B. Ocular lesions in HTLV-1 infected patients from Salvador, State of Bahia: the city with the highest prevalence of this infection in Brazil. Rev Soc Bras Med Trop 2009;42:633-637
18. Singer EJ, Valdes-Sueiras M, Commins D, Levine A. Neurologic presentations of AIDS. Neurol Clin 2010;28:253-275
19. Jabs DA, Green WR, Fox R, Polk BF, Bartlett JG. Ocular manifestations of acquired immune deficiency syndrome. Ophthalmology 1989;96: 1092-1099
20. Hayes EB, Sejvar JJ, Zaki SR, Lanciotti RS, Bode AV, Campbell GL. Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis 2005;11:1174-1179
21. Kramer LD, Li J, Shi PY. West Nile virus. Lancet Neurol 2007;6:171-181
22. Khairallah M, Ben Yahia S, Ladjimi A, Zeghidi H, Ben Romdhane F, Besbes L, et al. Chorioretinal involvement in patients with West Nile virus infection. Ophthalmology 2004;111:2065-2070
23. Garg RK. Subacute sclerosing panencephalitis. J Neurol 2008;255:1861-1871
24. Cochereau-Massin I, Gaudric A, Reinert P, LeHoang P, Rousselie F, Coscas G. Changes in the fundus in subacute sclerosing panencephalitis. Apropos of 23 cases J Fr Ophtalmol 1992;15:255-261
25. Smith GT, Goldmeier D, Migdal C. Neurosyphilis with optic neuritis: an update. Postgrad Med J 2006;82:36-39
26. Ghanem KG. Neurosyphilis: A historical perspective and review. CNS Neurosci Ther 2010;16:157-168
27. Kestelyn P. Syphilis. In: Gupta A, Gupta V, Herbort CP, Khairallah M (eds). Uveitis: Text and Imaging. 1st ed. Jaypee Brothers Medical Publishers Ltd; 2009: 590-600
28. Winward KE, Smith JL, Culbertson WW, Paris-Hamelin A. Ocular Lyme borreliosis. Am J Ophthalmol 1989;108:651-657
29. Halperin JJ. Nervous system Lyme disease. J R Coll Physicians Edinb 2010;40:248-255
30. Zajkowska JM, Hermanowska-Szpakowicz T, Kondrusik M, Pancewicz SA. Neurologic syndromes in Lyme disease. Pol Merkur Lekarski 2000;9:584-588
31. Cardoso S. HIV-related movement disorders: epidemiology, pathogenesis and management. CNS Drugs 2002;16:663-668
32. Pavesio C. Toxoplasmosis. In: Gupta A, Gupta V, Herbort CP, Khairallah M (eds). Uveitis: Text and Imaging. 1st ed. New Delhi: Jaypee Brothers Medical Publishers Ltd; 2009: 661-672
33. Chan RY. Ophthalmic Whipple's Disease. www.uveitis.org/medical/articles/case/whip.Html
34. Dobbins WO 3rd. HLA antigens in Whipple's disease. Arthritis Rheum 1987;30:102-105
35. Easley RB, Cooperstock MS, Tobias JD. Cat-scratch disease causing status epilepticus in children. South Med J 1999;92:73-76
36. Carithers HA, Margileth AM. Cat-scratch disease. Acute encephalopathy and other neurologic manifestations. Am J Dis Child 1991;145:98-101
37. Roe RH, Michael Jumper J, Fu AD, Johnson RN, Richard McDonald H, Cunningham ET. Ocularbartonella infections. Int Ophthalmol Clin 2008;48: 93-105
38. Herman, JS, Chiodini PL. Gnathostomiasis, another emerging imported disease. Clinical Microbiology Reviews 2009;22:484-492
39. Minagar A, Fowler M, Harris MK, Jaffe SL. Neurologic presentations of systemic vasculitides. Neurol Clin 2010;28:171-184
40. Nowack R, Wachtler P, Kunz J, Rasmussen N. Cranial nerve palsy in Wegener's granulomatosislessons from clinical cases. J Neurol 2009;256:299-304
41. Delalande S, de Seze J, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D, et al. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore) 2004;83:280-291
42. Mori K, Iijima M, Koike H, Hattori N, Tanaka F, Watanabe H, et al. The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy. Brain 2005;128:2518-2534
43. Isshi K, Hirohata S. Differential roles of the antiribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus. Arthritis Rheum 1998;41:1819-1827
44. Sivaraj RR, Durrani OM, Denniston AK, Murray PI, Gordon C. Ocular manifestations of systemic lupus erythematosus. Rheumatology (Oxford) 2007;46:1757-1762
45. Chapelon-Abric C. Neurosarcoidosis. Rev Neurol (Paris) 2006;162:1173-1188
46. Pawate S, Moses H, Sriram S. Presentations and outcomes of neurosarcoidosis: a study of 54 cases. QJM 2009;102:449-460
47. Spencer TS, Campellone JV, Maldonado I, Huang N, Usmani Q, Reginato AJ. Clinical and magnetic resonance imaging manifestations of neurosarcoidosis. Semin Arthritis Rheum 2005;34: 649-661
48. Menezo V, Lobo A, Yeo TK, du Bois RM, Lightman S. Ocular features in neurosarcoidosis. Ocul Immunol Inflamm 2009;17:170-178
49. Akman-Demir G, Serdaroglu P, Tasçi B. Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group. Brain 1999;122:2171-2182
50. Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V, et al. The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 2003;82: 60-76
51. Hamdan A, Mansour W, Uthman I, Masri AF, Nasr F, Arayssi T. Behçet's disease in Lebanon: clinical profile, severity and two-decade comparison. Clin Rheumatol 2006;25:364-367
52. Benamour S, Naji T, Alaoui FZ, El-Kabli H, El-Aidouni S. Neurological involvement in Behçet's disease. 154 cases from a cohort of 925 patients and review of the literature. Rev Neurol (Paris) 2006;162:1084-1090
53. B'chir Hamzaoui S, Harmel A, Bouslama K, Abdallah M, Ennafaa M, M'rad S, et al. Behçet's disease in Tunisia. Clinical study of 519 cases. Rev Med Interne 2006;27:742-750
54. Borhani-Haghighi A, Samangooie S, Ashjazadeh N, Nikseresht A, Shariat A, Yousefipour G, et al. Neurological manifestations of Behçet's disease. Saudi Med J 2006;27:1542-1546
55. Houman MH, Hamzaoui-B'Chir S, Ben Ghorbel I, Lamloum M, Ben Ahmed M, Abdelhak S, et al. Neurologic manifestations of Behçet's disease: analysis of a series of 27 patients. Rev Med Interne 2002;23:592-606
56. Serdaroglu P. Behçet's disease and the nervous system. J Neurol 1998;245:197-205
57. Siva A, Kantarci OH, Saip S, Altintas A, Hamuryudan V, Islak C, et al. Behçet's disease: diagnostic and prognostic aspects of neurological involvement. J Neurol 2001;248:95-103
58. Siva A, Altintas A, Saip S. Behçet's syndrome and the nervous system. Curr Opin Neurol 2004;17: 347-357
59. Ho CL, Deruytter MJ. Manifestations of Neuro-Behcet's disease. Report of two cases and review of the literature. Clin Neurol Neurosurg 2005;107: 310-314
60. Borhani-Haghighi A, Pourmand R, Nikseresht AR. Neuro-Behçet disease. A review. Neurologist 2005;11:80-89
61. Pearce JM. Neurological symptoms of Adamantiades-Behçet's syndrome. J Neurol Neurosurg Psychiatry 2006;77:956-957
62. Diri E, Espinoza LR. Neuro-Behçet's syndrome: differential diagnosis and management. Curr Rheumatol Rep 2006;8:317-322
63. Yesilot N, Shehu M, Oktem-Tanor O, Serdaroglu P, Akman-Demir G. Silent neurological involvement in Behçet's disease. Clin Exp Rheumatol 2006;24:S65-70
64. Chae EJ, Do KH, Seo JB, Park SH, Kang JW, Jang YM, et al. Radiologic and clinical findings of Behçet disease: comprehensive review of multisystemic involvement. Radiographics 2008;28:e31.
65. Birol A, Ulkatan S, Koçak M, Erkek E. Peripheral neuropathy in Behçet's disease. J Dermatol 2004;31:455-459
66. Tugal-Tutkun I. Behçet's Uveitis. Middle East Afr J Ophthalmol 2009;16:219-224
67. Akman-Demir G, Ayranci O, Kurtuncu M, Vanli EN, Mutlu M, Tugal-Tutkun I. Cyclosporine for Behçet's uveitis: is it associated with an increased risk of neurological involvement? Clin Exp Rheumatol 2008;26:S84-90
68. Nordlund JJ. The lives of pigment cells. Dermatol Clin 1986;4:407-418
69. Damico FM, Bezerra FT, Silva GC, Gasparin F, Yamamoto JH. New insights into Vogt-Koyanagi-Harada disease. Arq Bras Oftalmol 2009;72:413-420
70. Goldberg AC, Yamamoto JH, Chiarella JM, Marin ML, Sibinelli M, Neufeld R, et al. HLA-DRB1*0405 is the predominant allele in Brazilian patients with Vogt-Koyanagi-Harada disease. Hum Immunol 1998;59:183-188
71. Damico FM, Kiss S, Young LH. Vogt-Koyanagi-Harada disease. Semin Ophthalmol 2005;20:183-190
72. Andreoli CM, Foster CS. Vogt-Koyanagi-Harada disease. Int Ophtalmol Clin 2006;46:111-122
73. Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol 1995;39:265-292
74. Read RW. Vogt-Koyanagi-Harada disease. Ophthalmol Clin North Am 2002;15:333-341
75. Nakao K, Mizushima Y, Abematsu N, Goh N, Sakamoto T. Anterior ischemic optic neuropathy associated with Vogt-Koyanagi-Harada disease. Graefes Arch Clin Exp Ophtalmol 2009;247:1417-1425
76. Touitou V, Escande C, Bodaghi B, Cassoux N, Wechsler B, Lemaitre C, et al. Diagnostic and therapeutic management of Vogt-Koyanagi-Harada syndrome. J Fr Ophtalmol 2005;28:9-16
77. Keino H, Goto H, Mori H, Iwasaki T, Usui M. Association between severity of inflammation in CNS and development of sunset glow fundus in Vogt-Koyanagi-Harada disease. Am J Ophthalmol 2006;141:1140-1142
78. Herbort CP, Mantovani A, Bouchenaki N. Indocyanine green angiography in Vogt-Koyanagi-Harada disease: angiographic signs and utility in patient follow-up. Int Ophthalmol 2007;27:173-182
79. Kawaguchi T, Horie S, Bouchenaki N, Ohno-Matsui K, Mochizuki M, Herbort CP. Suboptimal therapy controls clinically apparent disease but not subclinical progression of Vogt-Koyanagi-Harada disease. Int Ophthalmol 2010;30:41-50
80. Cimino L, Auer C, Herbort CP. Sensitivity of indocyanine green angiography for the follow-up of active inflammatory choriocapillaropathies. Ocul Immunol Inflamm 2000;8:275-283
81. Çomu S, Verstraeten T, Rinkoff JS, Busis NA. Neurological manifestations of acute posterior multifocal placoid pigment epitheliopathy. Stroke 1996;27:996-1001
82. Susac JO. Susac's syndrome: the triad of microangiopathy of the brain and retina with hearing loss in women. Neurology 1994;44:591-593
83. O'Halloran HS, Pearson PA, Lee WB, Susac JO, Berger JR. Microangiopathy of the brain, retina, and cochlea (Susac syndrome): a report of five cases and a review of the literature. Ophthalmology 1998;105:1038-1044
84. Papo T, Biousse V, Lehoang P, Fardeau C, N'Guyen N, Huong DL, et al. Susac syndrome. Medicine (Baltimore) 1998;77:3-11
85. Egan RA, Nguyen TH, Gass DM, Rizzo JF 3rd, Tivnan J, Susac JO. Retinal Arterial Wall Plaques in Susac Syndrome. Am J Ophthalmol 2003;135:483-486
86. Park S, Abad S, Tulliez M, Monnet D, Merlat A, Gyan E, et al. Pseudouveitis: a clue to the diagnosis of primary central nervous system lymphoma in immunocompetent patients. Medicine (Baltimore) 2004;83:223-232
87. Küker W, Herrlinger U, Gronewaller E, Rohrbach JM, Weller M. Ocular manifestations of primary nervous system lymphoma: what can be expected from imaging? J Neurol 2002;249:1713-1716
88. Angioi-Duprez K, Taillandier L, Gérin M, Berrod JP, George JL, Maalouf T. Ocular involvement during primary central nervous system lymphoma. J Fr Ophtalmol 2002;25:147-153
89. Canaplé S, Rosa A, Deramond H, Desablens B, Legars D. Clinico-radiological data of 48 cases of immunocompetent primary cerebral lymphoma. Rev Neurol (Paris) 1996;152:528-535
90. Yang J. Ocular Lymphoma. www.uveitis.org/medical/articles/case/CNSNHL.html
91. Chan CC, Wallace DJ. Intraocular lymphoma: update on diagnosis and management. Cancer Control 2004;11:285-295
92. Coté TR, Mans A, Hardy CR, Yellin FJ, Hartge P. Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. AIDS/Cancer Study Group. J Natl Cancer Inst 1996;88:675-679
93. Hormigo A, Abrey L, Heinemann MH, DeAngelis LM. Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment. Br J Haematol 2004;126:202-208
94. Sierra Del Rio M, Rousseau A, Soussain C, Ricard D, Hoang-Xuan K. Primary CNS lymphoma in immunocompetent patients. Oncologist 2009;14: 526-539
95. Soussain C, Hoang-Xuan K. Primary central nervoussystem lymphoma: an update. Curr Opin Oncol 2009;21:550-558
96. Akpek EK, Ahmed I, Hochberg FH, Soheilian M, Dryja TP, Jakobiec FA, et al. Intraocularcentral nervous system lymphoma: clinical features, diagnosis, and outcomes. Ophthalmology 1999;106:1805-1810
97. Chan CC, Buggage RR, Nussenblatt RB. Intraocular lymphoma. Curr Opin Ophthalmol 2002;13:411-418
98. Wolf LA, Reed GF, Buggage RR, Nussenblatt RB, Chan CC. Vitreous cytokine levels. Ophthalmology 2003;110:1671-1672
99. Joshi DD, Anderson PM, Matsumoto J, Moir C, Shives T, Unni K, et al. Metastatic chondroblastoma with elevated creatine kinase and paraneoplastic neurologic autoimmunity. J Pediatr Hematol Oncol 2003;25:900-904
100. Ikawa M, Kuriyama M. Paraneoplastic retinopathy and optic neuropathy. Brain Nerve 2010;62:371-376.